JADBio AutoML (SaaS)
by JADBio
No code AI simplifying predictive modeling and feature selection for accelerated data insights.
JADBio is the first automated machine learning (AutoML) platform specifically designed for biomedical data. It is able to fully automate the production of predictive models and the identification of the predictive biomarkers from cross-sectional data, of the type that frequently occur in life sciences, e.g., (multi)omic, medical image, physiological signal, and RWE data and their combinations. JADBio automates even the most complex analysis workflows. Its AI intelligently recognizes the structure of the data and automatically determines which algorithms to apply, how to combine them, how to tune their parameters, and how to present and visualize the results. In doing so, it democratizes data science and machine learning to all stakeholders, Bioinformaticians, Doctors, Biologists, Clinicians
and Data Scientists. JADBio is the only such tool that can reliably scale down to very few samples and so it can be applied to small cohorts (e.g., < 50). It is the only one that can scale up to millions of measured quantities enabling the delivery of data insights across different company operations, driving 8-10x productivity gains and 5-7x cost reductions. JADBio has been used by more than 10,000 academics and organizations around the world, having appeared in more than 50 publications, leading to the creation of 2 data analysis platforms (one for multi-omics data analysis and another in chemoinformatics) and several discoveries that resulted in 3 patents and 2 recently emerging startups. Some of its highlights include models for
- disease type or sub-type diagnosis (e.g. cancer, mental health, diabetes, etc.),
- risk prediction (e.g. COVID-19),
- therapy efficacy in drug discovery or patient stratification (e.g. chemotherapy), and
- survival or adverse event time prognosis (e.g. metastasis, relapse).
What you get using JADBio
- Decision making rooted in data insights by AI/ML. o Uncover trends and actionable insights by leading proprietary tools and expertise
- Faster R&D discoveries o Augment your team's capacity and productivity, by reducing multifold the time and cost of research data analysis.
- Maximize impact by reduced failure rates o Identify valid biomarkers, early in the pipeline by trusted ML
- Real-world and multimodal data capabilities for personalized solutions o Tailor treatments to any type, any size, and any combination of data including molecular, imaging, clinical, and patient-reported/generated data.
- Enhanced agility
o Minimum error, rapid prototyping driving continuous improvement and outputs refinement.